A new model developed by a Medical School aims to improve cancer treatment decisions by predicting which patients will benefit from powerful immunotherapy drugs. Immunotherapy has shown significant promise in fighting cancer, but its effectiveness varies widely among patients.
The innovative AI tool seeks to address this challenge by providing a more accurate prediction of patient response. This advancement could help clinicians tailor treatment plans more effectively, ensuring that patients receive the most beneficial therapies.